Stanley-Laman Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.09M | Sell |
3,969
-1,493
| -27% | -$1.16M | 0.46% | 99 |
|
2025
Q1 | $4.51M | Buy |
5,462
+185
| +4% | +$153K | 0.69% | 48 |
|
2024
Q4 | $4.07M | Sell |
5,277
-3
| -0.1% | -$2.32K | 0.57% | 71 |
|
2024
Q3 | $4.68M | Sell |
5,280
-103
| -2% | -$91.3K | 0.66% | 51 |
|
2024
Q2 | $4.87M | Sell |
5,383
-4,438
| -45% | -$4.02M | 0.7% | 42 |
|
2024
Q1 | $7.64M | Sell |
9,821
-2,073
| -17% | -$1.61M | 1.07% | 15 |
|
2023
Q4 | $6.93M | Sell |
11,894
-1,558
| -12% | -$908K | 1.06% | 26 |
|
2023
Q3 | $7.23M | Sell |
13,452
-597
| -4% | -$321K | 1.23% | 13 |
|
2023
Q2 | $6.59M | Sell |
14,049
-1,678
| -11% | -$787K | 1.09% | 20 |
|
2023
Q1 | $5.4M | Sell |
15,727
-122
| -0.8% | -$41.9K | 0.96% | 23 |
|
2022
Q4 | $5.8M | Sell |
15,849
-662
| -4% | -$242K | 1.1% | 15 |
|
2022
Q3 | $5.34M | Sell |
16,511
-802
| -5% | -$259K | 1.01% | 22 |
|
2022
Q2 | $5.61M | Sell |
17,313
-1,689
| -9% | -$548K | 1% | 21 |
|
2022
Q1 | $5.44M | Buy |
19,002
+2,350
| +14% | +$673K | 0.75% | 31 |
|
2021
Q4 | $4.6M | Buy |
16,652
+1,422
| +9% | +$393K | 0.54% | 48 |
|
2021
Q3 | $3.52M | Buy |
15,230
+1,261
| +9% | +$291K | 0.46% | 49 |
|
2021
Q2 | $3.21M | Buy |
13,969
+1,304
| +10% | +$299K | 0.46% | 49 |
|
2021
Q1 | $2.37M | Buy |
12,665
+754
| +6% | +$141K | 0.39% | 62 |
|
2020
Q4 | $2.01M | Sell |
11,911
-617
| -5% | -$104K | 0.36% | 70 |
|
2020
Q3 | $1.85M | Buy |
+12,528
| New | +$1.85M | 0.41% | 64 |
|
2020
Q2 | – | Sell |
-2,002
| Closed | -$278K | – | 248 |
|
2020
Q1 | $278K | Buy |
+2,002
| New | +$278K | 0.08% | 206 |
|
2014
Q1 | – | Sell |
-29,601
| Closed | -$1.51M | – | 329 |
|
2013
Q4 | $1.51M | Buy |
+29,601
| New | +$1.51M | 0.33% | 96 |
|